prof. dr. G.N. (Gert) Moll
Honorary professor Protein Modification and Functionality
E-mail:
g.n.moll rug.nl
Research
Research units:
Postal address:
Nijenborgh7
9747 AG
Groningen
Netherlands
Phone: +31 50 363 4468Fax: +31 50 363 2368
Publications
LP2, the first lanthipeptide GPCR agonist in a human pharmacokinetics and safety study
Namsolleck, P., Richardson, A., Moll, G. N. & Mescheder, A., 27-Nov-2020, In : Peptides. 136, 170468.Research output: Contribution to journal › Article › Academic › peer-review
Export and modification of (poly)peptides in the lantibiotic way
Moll, G. N., Leenhouts, C. J., Kuipers, O. P. & Driessen, A. J. M., 4-Dec-2003, Patent No. WO03099862, 26-May-2003, Priority date 24-May-2002Research output: Patent
Biosynthesis of lanthionine-constrained agonists of G protein-coupled receptors
Moll, G. N., Kuipers, A., Rink, R., Bosma, T., de Vries, L. & Namsolleck, P., 14-Oct-2020, In : Biochemical Society Transactions. 48, 5, p. 2195-2203 9 p.Research output: Contribution to journal › Review article › Academic › peer-review
Does activation of the protective Renin-Angiotensin System have therapeutic potential in COVID-19?
Namsolleck, P. & Moll, G. N., 17-Aug-2020, In : Molecular medicine. 26, 1, 5 p., 80.Research output: Contribution to journal › Article › Academic › peer-review
High-throughput screening for substrate specificity-adapted mutants of the nisin dehydratase NisB
Zhao, X., Cebrian, R., Fu, Y., Rink, R., Bosma, T., Moll, G. N. & Kuipers, O. P., 19-Jun-2020, In : ACS Synthetic Biology. 9, 6, p. 1468-1478 11 p.Research output: Contribution to journal › Article › Academic › peer-review
Press / Media
Uit RUG voortgekomen Lanthio Pharma Chemische Start-up van het Jaar
24/11/2014
1 item of Media coverage
Press/Media: Public Engagement Activities › Popular
ID: 117694